The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill. (April 6)
Copyright 2016 The Associated Press, though the copyright in some contents and materials incorporated herein may be owned by third parties where so indicated. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.